| Application no. and date | 12782984.4 (espacenet) (Federated) (European Patent Register), 20120508 | | Patent/reg. no. and date | DK/EP 2707021, 20240221 | | Publication date | 20140319 | | Priority no. and date | US 201161484052 P, 20110509 | | EP pub. no. and date |
EP 2707021 20140319 | | Effective date | | | Applicant/owner | Minerva Biotechnologies Corporation, 40 Bear Hill Rd.
Waltham, MA 02451, US | | Applicant ref. no. | | | Inventor | BAMDAD, Cynthia, 356 Marlborough, Unit 2
Boston, MA 02115, US,
SMAGGHE, Benoit, J.,
Honolulu, HI 96814, US | | Representative | | | Opponent | | | IPC Class | A61K 38/18 (2006.01) , C07K 14/475 (2006.01) , C12N 15/00 (2006.01) , C12N 15/62 (2006.01) | | Title | GENETICALLY ENGINEERED GROWTH FACTOR VARIANTS | | Int. application no. | US2012036975 | | Int. publication no. | WO2012154759 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
